Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Norris Medicines Annual General Meeting

Norris Medicines approved the Directors' Report, Annual Report, and convening of the 35th Annual General Meeting for September 29, 2026.

Source

BSE filing, NSE: NORRIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Norris Medicines Ltd: key numbers

Share price
₹14.62
Market cap
₹14.62 Cr
Revenue (annual)
₹8.13 Cr
Net profit (annual)
₹-0.28 Cr
P/E (TTM)
-39.8×Sector 46.1×
Promoter holding
34.01%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Norris Medicines Ltd

All →

Other annual general meeting announcements

All →